|
Publicações seleccionadas
Moura J, Sørensen A, Leal E, Svendsen R, Carvalho L, Willemoes RJ, Jørgensen P, Jenssen H, Wengel J, Dalgaard L, Carvalho E. MicroRNA-155 inhibition restores Fibroblast Growth Factor 7 expression in diabetic skin and decreases wound inflammation. Scientific Reports, accepted.
Moura J, Madureira P, Leal EC, Fonseca AC, Carvalho E. Immune aging in diabetes and its implications in wound healing.Clin Immunol. 2019 Mar;200:43-54. doi: 10.1016/j.clim.2019.02.002. Epub 2019 Feb 5. Review. PubMed PMID: 30735729.
Silva C, Sampaio-Pinto V, Andrade S, Rodrigues I, Costa R, Guerreiro S, Carvalho E, Nascimento D, Pinto-do-Ó P, Soares R. Establishing a Link Between Endothelial Cell Metabolism and Vascular Behaviour in a Type 1 Diabetes Mouse Model. Cell Physiol Biochem 2019;52:1718-1731
Moura LIF, Lemos C, Ledent C, Carvalho E, Köfalvi A. Chronic insulinopenia/hyperglycemia decreases cannabinoid CB1receptor density and impairs glucose uptake in the mouse forebrain. Brain Res Bull. 2019 Feb 2;147:101-109. doi: 10.1016/j.brainresbull.2019.01.024. [Epub ahead of print] PubMed PMID: 30721768.
https://www.ncbi.nlm.nih.gov/labs/bibliography/1N_kjxvZYzSAP/bibliography/public/
https://scholar.google.com/citations?user=AHvtGSEAAAAJ&hl=en
https://orcid.org/0000-0001-6264-3632
Other Bibliography
2000 - PhD Thesis: Carvalho E, Molecular mechanisms of insulin resistance with emphasis on IRS-1 and PKB/Akt. ISBN 91-628-4230-7.
1994 - MSc Thesis: - Carvalho E, A study of the active sites of Angiotensin I-Converting Enzyme, Metal and inhibitor binding. ISBN 91-7032-948-6.
Over 100 Oral and Poster Presentations
Ver mais
Curriculum Vitae
Education and positions
2005 - present: Principal Investigator, CNC, University of Coimbra, Portugal
2013- Visiting research scientist – Arkansas Children’s Hospital (Nutrition Center) and University of Arkansas for Medical Sciences
(Donald W. Reynolds Institute on Aging), Little Rock, AR, USA
2007- 2008 Visiting research scientist in Medicine at the Division of Gastroenterology, BIDMC, Harvard Medical School, Boston, MA, USA
2001-2005: Post-Doctoral fellow, Division of Endocrinology, Department of Medicine, BIDMC, Harvard Medical School, Boston, MA, USA
2000: PhD, Molecular Medicine, Lundberg Laboratory for Diabetes Research, Gothenburg University, Gothenburg, Sweden
1994: MSc, Biochemistry, Gothenburg University, Gothenburg, Sweden
1991: BSc, Chemistry (Magna Cum Laude), Marymount Manhattan College, NYC, NY, USA
Senior Editor for:
Journal of Endocrinology (IF 4.0)
Journal of Molecular Endocrinology (IF 3.3)
Awards and Funding
1/1/2019-12/30/2020 COM Child Health project grant (PI)
Title: MicroRNAs as markers of disturbed adipose tissue function and inflammation - a potential mechanism for diabetes development in obesity
Funds: $50K
1/1/2019 – 12/30/2019 COM Sturgis project grant (PI)
Title: Role of Regulatory T-cells in Obesity-Linked Insulin Resistance and Diabetes
Funds: $26K
01/01/2019-12/30/2020 The Portuguese Transplant Society (SPT) (PI)
Title: CD20+ T Cells as a biomarker of inflammatory status and a promising target against cardiac rejection in heart transplanted patients
Funds: 10K Euros
2017-2019: Agency: ABI/ACHRI: (Co-PI)
Discovery Acceleration Initiative/Program Project Planning Grants
Title: Establishing the presence of mitochondrial dysfunction and oxidative stress and the relationships with resting energy expenditure and fatty acid oxidation in childhood obesity
Funds: $100 K
2017-2019: Agency: NIH – COBRE - primary project (Project Leader)
Title: Assessment of oxidative capacity in obese children
Funds: $330 K
2017-2019 Diabetes UK: "Inhibition of macrophage protein tyrosine phosphatase 1B (PTP1B) as a novel therapy for improved wound healing in diabetes" (165 K Pounds)
2017-2021- H2020-MSCA-ITN-2016/ Proposal: 721236 -TREATMENT Marie Skłodowska-Curie actions (3.7 million Euros)
2017-2018 - INFARMED - Diabetes: Microbes and therapies (100 K Euros)
2016 - Award from Portuguese Transplantation Society
2016-2018 - EFSD European Research Programme in Microvascular Complications of Diabetes supported by Novartis
"Combination therapy synergistically accelerates diabetic wound closure"
2009 -2016 - 23 Albert Renolds Fellowships for Young Investigators from EFSD
2013 - Bolsa Dr. M.M. Almeida Ruas SPD/Novonordisk - EC
2013-2016 - EXCL/DTP-PIC/0069/2012, “Anticipating diabetes and diabetic wounding for siblings of Type 2 diabetics”
2013-2014 - EXPL/BIM-MED/0492/2012, “Mechanisms and treatment strategies of impaired wound healing in diabetes” 2012-2013
2013-2014 - EFSD/JDRF/Novo Nordisk European Programme in Type 1 Diabetes Research, “Promoting endothelial progenitor cell function in diabetic wound healing”
2012 - Albert Renold Fellowships for Young Scientists - CFM
2012 - Bolsa Dr. M.M. Almeida Ruas SPD/ Novo Nordisk - EL
2012 - PTDC/SAU-FAR/121109/2010, “Neuropeptide release in wounds: a new therapeutic approach for the treatment of diabetic foot ulceration”
2011 - Prémio GIFT/SPD (Sociedade Portuguesa Diabetologia)
2010 - Prémio Hargreaves - SPD/JABA.
2010 - PTDC/SAU-MII/098567/2008, “Dissecting the molecular mechanisms of wound healing in diabetes - the role of neuropeptides”
2010 - PTDC/SAU-OSM/104124/2008, “Molecular mechanisms of heart failure – the role of the adipocyte as an endocrine organ”
2009-2010 - EFSD/JDRF/Novo Nordisk European Programme in Type 1 Diabetes Research, “Dissecting mechanisms of neuronal dysfunction in wound healing in diabetes type 1”
2006-2009 - POCTI/SAU-MMO/57598/2004, “Study of the possible environmental and molecular mechanisms responsible for Insulin Resistance, Type 2 Diabetes and Obesity in Portugal”
2006-2008 – Startup package from the Center for Neurosciences and Cell Biology - PT
2004-2007 - Research fellowship from the Swedish Research Council
2004 - EASD/ Eli Lilly Research Fellowship in Diabetes and Metabolism
2002 - Travel award American Diabetes Association
2001 - Post doctoral grant from The Swedish Society for Medical Research
2001 - Best thesis of the year 2000, the Swedish Foundation for the Study of Diabetes
2001 - Travel award VIII International Symposium on Insulin Receptor/Insulin Action
2001 - Travel award from Bayer
2000 - Post doctoral grant from the Hellmuth Hertz Foundation
2000 - Travel award Wenner-Gren
2000 - Travel award from Tore Nilsons Stiftelse för Medicinsk Forskning
2000 - Post doctoral grant from the Swedish Foundation for the Study of Diabetes
2000 - Project award KVA (The Royal Swedish Academy of Sciences)
2000 - Project grant from Novo Nordisk
1999 - Research grant from Teknikbrostiftelsen in Gothenburg
1997 - Travel award American Diabetes Association
1993-1997 - Travel award from FEBS (Federation of European Biochemical Societies)/NATO
1990 - Member of Alpha Chi
Professional memberships
2000 - present European Association for the Study of Diabetes (EASD/EFSD)
2015 - 2017 American Diabetes Association (ADA)
2015 - 2017 American Physiological Society (APS)
2015 - 2016 The Obesity Society (TOS)
2011 Advisory Board Founder Member, The Portuguese Diabetes Association (APDP) http://www.idf.org/node/1811
2008 Portuguese Diabetes Foundation (SPD)
1999-2005 Swedish Foundation for the Study of Diabetes (SFSD)
AD HOC International Grant Reviewer
2017 – present Wellcome Trust
2017 – present Fonds de Recherche du Quebec - CONACYT
2014 - present. ANR - French funding agency
2014 - present Diabetes UK
2013 - present MRC UK – Medical Research Council
2012 - present Polish funding agency: FNP: Fundacja na rzecz Nauki Polskiej
AD HOC Reviewer for over 30 scientific journals
Acta Biomaterialia; Acta Diabetologica; Biochemical Pharmacology; Biochemistry & Pharmacology; British Journal of Medicine and Medical Research; British Journal of Pharmacology; Cardiovascular Diabetology; Diabetes Research and Clinical Practice; European Journal of Pharmaceutical Sciences; Experimental Biology and Medicine; International Journal of Obesity; International Wound Journal; Journal of Applied Biomedicine; Journal of Clinical Investigation; Journal of Diabetes & Metabolism; Metabolism; Molecular and Cellular Endocrinology; PLOS ONE; Wound repair and Regeneration.
Awards and Funding
2018-2021: Agency: Portuguese Foundation for Science and technology (Co-I)
02/SAICT/2017 – SAICT (projects IC&DT)
Title: Contribution of Psychological Factors in Diabetic Foot Ulcer Healing; in Physiological Indicators of Wound Healing Prognosis and Quality of Life: A Randomized Longitudinal Effectiveness Evaluation Study. Funds: 190 K Euros
2018 Portuguese Diabetes Society (SPD) – (5 K Euros)
2017-2019: Agency: ABI/ACHRI: (Co-PI)
Discovery Acceleration Initiative/Program Project Planning Grants
Title: Establishing the presence of mitochondrial dysfunction and oxidative stress and the relationships with resting energy expenditure and fatty acid oxidation in childhood obesity
Funds: $100 K
2017-2019: Agency: NIH – COBRE - primary project (Project Leader)
Title: Assessment of oxidative capacity in obese children
Funds: $330 K
2017-2019 Diabetes UK: "Inhibition of macrophage protein tyrosine phosphatase 1B (PTP1B) as a novel therapy for improved wound healing in diabetes" (165 K Pounds)
2017-2021- H2020-MSCA-ITN-2016/ Proposal: 721236 -TREATMENT Marie Skłodowska-Curie actions (3.7 million Euros)
2017-2018 - INFARMED - Diabetes: Microbes and therapies (100 K Euros)
2016 - Award from Portuguese Transplantation Society
2016-2018 - EFSD European Research Programme in Microvascular Complications of Diabetes supported by Novartis
"Combination therapy synergistically accelerates diabetic wound closure"
2009 -2016 - 23 Albert Renolds Fellowships for Young Investigators from EFSD
2013 - Bolsa Dr. M.M. Almeida Ruas SPD/Novonordisk - EC
2013-2016 - EXCL/DTP-PIC/0069/2012, “Anticipating diabetes and diabetic wounding for siblings of Type 2 diabetics”
2013-2014 - EXPL/BIM-MED/0492/2012, “Mechanisms and treatment strategies of impaired wound healing in diabetes” 2012-2013
2013-2014 - EFSD/JDRF/Novo Nordisk European Programme in Type 1 Diabetes Research, “Promoting endothelial progenitor cell function in diabetic wound healing”
2012 - Albert Renold Fellowships for Young Scientists - CFM
2012 - Bolsa Dr. M.M. Almeida Ruas SPD/ Novo Nordisk - EL
2012 - PTDC/SAU-FAR/121109/2010, “Neuropeptide release in wounds: a new therapeutic approach for the treatment of diabetic foot ulceration”
2011 - Prémio GIFT/SPD (Sociedade Portuguesa Diabetologia)
2010 - Prémio Hargreaves - SPD/JABA.
2010 - PTDC/SAU-MII/098567/2008, “Dissecting the molecular mechanisms of wound healing in diabetes - the role of neuropeptides”
2010 - PTDC/SAU-OSM/104124/2008, “Molecular mechanisms of heart failure – the role of the adipocyte as an endocrine organ”
2009-2010 - EFSD/JDRF/Novo Nordisk European Programme in Type 1 Diabetes Research, “Dissecting mechanisms of neuronal dysfunction in wound healing in diabetes type 1”
2006-2009 - POCTI/SAU-MMO/57598/2004, “Study of the possible environmental and molecular mechanisms responsible for Insulin Resistance, Type 2 Diabetes and Obesity in Portugal”
2006-2008 – Startup package from the Center for Neurosciences and Cell Biology - PT
2004-2007 - Research fellowship from the Swedish Research Council
2004 - EASD/ Eli Lilly Research Fellowship in Diabetes and Metabolism
2002 - Travel award American Diabetes Association
2001 - Post doctoral grant from The Swedish Society for Medical Research
2001 - Best thesis of the year 2000, the Swedish Foundation for the Study of Diabetes
2001 - Travel award VIII International Symposium on Insulin Receptor/Insulin Action
2001 - Travel award from Bayer
2000 - Post doctoral grant from the Hellmuth Hertz Foundation
2000 - Travel award Wenner-Gren
2000 - Travel award from Tore Nilsons Stiftelse för Medicinsk Forskning
2000 - Post doctoral grant from the Swedish Foundation for the Study of Diabetes
2000 - Project award KVA (The Royal Swedish Academy of Sciences)
2000 - Project grant from Novo Nordisk
1999 - Research grant from Teknikbrostiftelsen in Gothenburg
1997 - Travel award American Diabetes Association
1993-1997 - Travel award from FEBS (Federation of European Biochemical Societies)/NATO
1990 - Member of Alpha Chi
Hobbies
Traveling (visited over 35 countries)
Reading, hiking, climbing, cooking, gardening, swimming and biking with friends
Languages
English, Swedish, Portuguese, Spanish, French and Italian (basic).
Moura L, Dias A, Suesca E, Casadiegos S, Leal E, Fontanilla M, Carvalho L, Sousa H, Carvalho E. Neurotensin-loaded collagen dressings reduce inflammation and improve wound healing in diabetic mice. Biochim Biophys Acta. 2014 Jan;1842(1):32-43. IF 4.9
Moura LI, Dias A, Leal E, Carvalho L, Sousa H, Carvalho E. Chitosan-based dressings loaded with neurotensin-an efficient strategy to improve early diabetic wound healing. Acta Biomater. 2014 Feb;10(2):843-57. IF 5.1
Tecilazich F, Dinh T, Pradhan L, Leal E, Tellechea A, Kafanas A, Gnardellis C, Toxavidis V, Tigges C, Carvalho E, Lyons T, Veves A. Role of Endothelial Progenitor Cells and Inflammatory Cytokines in Healing of Diabetic Foot Ulcers, PLoS One. 2013 Dec16;8(12):e83314. IF 3.7
Moura LI, Cruz MT, Carvalho E. The effect of neurotensin in human keratinocytes– implication on impaired wound healing in diabetes. Exp Biol Med (Maywood). 2014;239(1):6-12. IF 2.8
Moura LI, Silva L, Leal EC, Tellechea A, Cruz MT, Carvalho E. Neurotensin Modulates the Migratory and Inflammatory Response of Macrophages under Hyperglycemic Conditions. Biomed Res Int. 2013:941764. IF 2.9.
Moura J, da Silva L, Cruz MT, Carvalho E. Molecular and cellular mechanisms of bone morphogenetic proteins and activins in the skin: potential benefits for wound healing. Arch Dermatol Res. 2013 Sep;305(7):557-69. IF 2.7
Moura LI, Dias AM, Carvalho E*, de Sousa HC*. Recent advances on the development of wound dressings for diabetic foot ulcer treatment--a review. Acta Biomater. 2013 Jul;9(7):7093-114. IF 5.1
Soares E, Prediger RD, Nunes S, Castro AA, Viana SD, Lemos C, De Souza CM, Agostinho P, Cunha RA, Carvalho E, Fontes Ribeiro CA, Reis F, Pereira FC. Spatial memory impairments in a prediabetic rat model. Neuroscience. 2013 Oct 10;250:565-77. IF 3.1
Nunes S, Soares E, Fernandes J, Viana S, Carvalho E, Pereira FC, Reis F. Early cardiac changes in a rat model of prediabetes: brain natriuretic peptide overexpression seems to be the best marker. Cardiovasc Diabetol. 2013 Mar 7;12(1):44. IF 4.2
Lopes P, Fuhrmann A, Sereno J, Pereira MJ, Nunes P, Pedro J, Melão A, Reis F, Carvalho E. Effects of cyclosporine and sirolimus on insulin-stimulated glucose transport and glucose tolerance in a rat model. Transplant Proc. 2013 Apr;45(3):1142-8. IF 1
Sereno J, Parada B, Rodrigues-Santos P, Lopes PC, Carvalho E, Vala H, Teixeira-Lemos E, Alves R, Figueiredo A, Mota A, Teixeira F, Reis F. Serum and renal tissue markers of nephropathy in rats under immunosuppressive therapy: cyclosporine versus sirolimus. Transplant Proc. 2013 Apr;45(3):1149-56. IF 1
Tellechea A, Kafanas A, Leal EC, Tecilazich F, Kuchibhotla S, Auster ME, Kontoes I, Paolino J, Carvalho E, Nabzdyk LP, Veves A. Increased skin inflammation and blood vessel density in human and experimental diabetes. Int J Low Extrem Wounds. 2013;12(1):4-11. IF 1.3
Pereira MJ, Palming J, Rizell M, Aureliano M, Carvalho E, Svensson MK, Eriksson JW. The immunosuppressive agents rapamycin, cyclosporin A and tacrolimus increase lipolysis, inhibit lipid storage and alter expression of genes involved in lipid metabolism in human adipose tissue. Mol Cell Endocrinol. 2013 Jan 30;365(2):260-9. IF 4
Cherian S, Lupaschuk DG and Carvalho E. Cellular cross-talk between epicardial adipose tissue and myocardium in relation to the pathogenesis of cardiovascular disease. Am J Physiol Endocrinol Metab. 2012 Oct;303(8):E937-49. IF 4.5
M. Pereira, J Palming, M Rizell, M Aureliano, E Carvalho, MK Svensson, JW Eriksson. mTOR inhibition with rapamycin causes impaired insulin signalling and glucose uptake in human subcutaneous and omental adipocytes. Mol Cell Endocrinol. 2012;355(1):96-105. IF 4
J Sereno, AM Romão, B Parada, P Lopes, E Carvalho, F Teixeira, F Reis. Cardiorenal benefits of early versus late cyclosporine to sirolimus conversion in a rat model. J Pharmacol Pharmacother. 2012 Apr;3(2):143-8.
Silva L, Neves B, Moura L, Rosete T and Carvalho E, Neurotensin downregulates the pro-inflammatory properties of skin-dendritic cells and increases epidermal growth factor expression. Biochim Biophys Acta. 2011 Oct;1813(10):1863-71. IF 4.8
Pedroso S, Tellechea A, Moura L, Fidalgo-Carvalho I, Duarte J, Carvalho E, Ferreira L. Improved survival, vascular differentiation and wound healing potential of umbilical cord blood stem cells co-cultured with endothelial cells in a biomimetic gel. PLoS One 2011,6(1):e16114. IF 3.7
Silva L, Carvalho E* and Rosete T*. Role of neuropeptides in skin inflammation and its involvement in diabetic wound healing. Expert Opin Biol Ther. 2010 10(10):1427-39. IF 3.3
Passadouro M, Melao A, Pedro J, Metelo MA, Faneca H, Carvalho E and Castro M. Study of the antidiabetic capacity of the VO(dmpp)2 complex. Journal of Inorganic Biochemistry. 2010. 104:987-992. IF 3.4
Tellechea A, Leal E, Veves A and Carvalho E. Inflammatory and angiogenic abnormalities in diabetic wound healing: role of neuropeptides and therapeutic perspectives. The Open Circulation & Vascular Journal. 2010, 3: 43-55.
Pereira MJ, Carvalho E, Eriksson J, Crans DC and Aureliano M. Decavanadate and insulin mimetic vanadium compounds effects on adipocytes glucose uptake, Journal of Inorganic Biochemistry. 2009, 103, 1687–1692. IF 3.4
Carvalho E. http://www.easd.org/easdwebfiles/cme/scientists-training-course/ST-Report2008.html EASD report, Diabetologia 2009, 52(1).
Nunes PM, Carvalho E, Jones JG. Elimination of glucose contamination from adipocyte glycogen extracts. Carbohydr Res. 2008 343(9):1486-1489. IF 2.0
Karagiannides I, Torres D, Tseng Y-H, Bowe C, Carvalho E, Espinoza D, Pothoulakis C and Kokkotou E. Substance P as a novel anti-obesity target. Gastroenterology. 2008 134(3):747-55. IF 12.8
Carvalho E, Kotani K, Peroni OD, Kahn BB. Adipose-specific overexpression of GLUT4 reverses insulin resistance and diabetes in mice lacking GLUT4 selectively in muscle. Am J Physiol Endocrinol Metab. 2005, 289(4):E551-61. IF 4.5
Carvalho E, Schellhorn SE, Zabolotny JM, Martin S, Tozzo E, Peroni OD, Houseknecht KL, Mundt A, James DE, Kahn BB. GLUT4 overexpression or deficiency in adipocytes of transgenic mice alters the composition of GLUT4 vesicles and the subcellular localization of GLUT4 and insulin-responsive aminopeptidase. J Biol Chem. 2004, 279(20):21598-605. IF 5.3
Yang X, Jansson P-A, Nagaev I, Jack M, Carvalho E, Sunnerhagen KS, Cam MC, Cushman SW, Smith U, Evidence of impaired adipogenesis in insulin resistance. Biochem Biophys Res Commun. 2004, 317(4):1045-51. IF 2.4, Cit 123
Jansson P-A, Pellmé F, Hammarstedt A, Sandqvist M, Caidahl K, Forsberg M, Volkmann R, Carvalho E, Funahashi T, Matsuzawa Y, Wiklund O, Yang X, Taskinen M-R, Smith U, A novel cellular marker of insulin resistance and early atherosclerosis in man is related to impaired fat cell differentiation and low adiponectin. FASEB J. 2003 17(11):1434-40. IF 5.7
Carvalho E, Jansson P-A, Nagaev I, Wenthzel A-M, and Smith U, Defficient IRS-1 and Glut4 protein expression in adipocytes from insulin resistant subjects. FASEB J 2001 15(6):1101-3. IF 5.7
Carvalho E, Eliasson B, Wesslau C, and Smith U, Impaired phosphorylation and insulin-stimulated translocation to the plasma membrane of Protein Kinase B/Akt in adipocytes from type 2 diabetic subjects. Diabetologia 2000, 43:1107-1115. IF 6.5
Smith U, Carvalho E, Mosialou E, Formisano P, and Rondinone C. PKB inhibition prevents the stimulatory effect of insulin on glucose transport and protein translocation but not the antilipolytic effect in rat adipocytes. Biochem Biophys Res Commun 2000, 268:315-20. IF 2.4
Carvalho E, Rondinone C, Smith U, Insulin resistance in fat cells from obese Zucker rats – Evidence for an impaired activation and translocation of protein kinase B and glucose transporter 4. Mol Cell Biochem 2000, 206:7-16. IF 2.3
Rondinone C, Carvalho E, Rahn T, Manganiello VC, Degerman E, and Smith U, Phosphorylation of PDE3B by phosphatidylinositol 3-kinase associated with the insulin receptor. J Biol Chem 2000, 275:10093-98. IF 5.3
Smith U, Axelsen M, Carvalho E, Eliasson B, Jansson P-A, and Wesslau C, Insulin signaling and action in fat cells-associaction with insulin resistance and NIDDM. Ann NY Acad Sci 1999, 892:119-126. IF 3.1
Carvalho E, Jansson P-A, Axelsen M, Eriksson JW, Huang X, Groop L, Rondinone C, Sjöström L, and Smith U, Low cellular IRS-1 gene and protein expression predict insulin resistance and NIDDM. FASEB J 1999, 13:2173-2178. IF 5.7
Rondinone C, Carvalho E, Wesslau C, and Smith U, Impaired glucose transport and protein kinase B activation by insulin, but not okadaic acid, in adipocytes from subjects with Type II diabetes mellitus. Diabetologia 1999, 42:819-825. IF 6.5
Carvalho E, Aasa R, and Göthe P-O, Electron Paramagnetic Resonance studies of Cobalt-substituted Angiotensin I-Converting Enzyme. J Inorg Biochem. 1996, 62:147-153. IF 3.2
Carvalho E, Gothe P-O, Bauer R, Danielsen E, and Hemmingsen L, Effect of inhibitors on the coordination geometries of cadmium at the metal sites in angiotensin I-converting enzyme. Eur J Biochem 1995, 234:780-785. IF 3.6
|
